Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis.

[1]  B. Levy,et al.  DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. , 2016, European journal of pharmacology.

[2]  M. Abdelsaid,et al.  A lipidomic screen of hyperglycemia-treated HRECs links 12/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase , 2015, Journal of Lipid Research.

[3]  E. Duh,et al.  Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids. , 2015, Biochimica et biophysica acta.

[4]  R. Romero,et al.  Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  K. Maddipati,et al.  12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase , 2013, PloS one.

[6]  Wenlian Zhang,et al.  Identification of the Orphan G Protein-coupled Receptor GPR31 as a Receptor for 12-(S)-Hydroxyeicosatetraenoic Acid* , 2011, The Journal of Biological Chemistry.

[7]  G. Liou,et al.  Retinal Microglial Activation and Inflammation Induced by Amadori-Glycated Albumin in a Rat Model of Diabetes , 2011, Diabetes.

[8]  Sun Young Park,et al.  Increased Expression and Activity of 12-Lipoxygenase in Oxygen-Induced Ischemic Retinopathy and Proliferative Diabetic Retinopathy , 2011, Diabetes.

[9]  Daling Zhu,et al.  15-Hydroxyeicosatetraenoic acid (15-HETE) protects pulmonary artery smooth muscle cells against apoptosis via HSP90. , 2010, Life sciences.

[10]  Tien Yin Wong,et al.  Diabetic retinopathy , 2010, The Lancet.

[11]  Yi Zhu,et al.  Vascular endothelial growth factor up‐regulates the expression of intracellular adhesion molecule‐1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide , 2009, Chinese medical journal.

[12]  J. Nadler,et al.  5-Lipoxygenase, but Not 12/15-Lipoxygenase, Contributes to Degeneration of Retinal Capillaries in a Mouse Model of Diabetic Retinopathy , 2008, Diabetes.

[13]  A. Adamis,et al.  Immunological mechanisms in the pathogenesis of diabetic retinopathy , 2008, Seminars in Immunopathology.

[14]  J. Shaw,et al.  Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies , 2008, The Lancet.

[15]  Tien Yin Wong,et al.  Relationship of Retinal Vascular Caliber With Diabetes and Retinopathy , 2008, Diabetes Care.

[16]  W. Glasgow,et al.  15(S)-HETE production in human retinal microvascular endothelial cells by hypoxia: Novel role for MEK1 in 15(S)-HETE induced angiogenesis. , 2007, Investigative ophthalmology & visual science.

[17]  K. Tsubota,et al.  Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. , 2007, Investigative ophthalmology & visual science.

[18]  C. Funk.  Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[19]  M. Schwartz,et al.  12/15-Lipoxygenase Regulates Intercellular Adhesion Molecule-1 Expression and Monocyte Adhesion to Endothelium Through Activation of RhoA and Nuclear Factor-&kgr;B , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[20]  Ulrich Schraermeyer,et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  N. Congdon,et al.  Important causes of visual impairment in the world today. , 2003, JAMA.

[22]  Shao-fen Lin,et al.  Increased expression of intercellular adhesion molecule-1, vascular cellular adhesion molecule-1 and leukocyte common antigen in diabetic rat retina. , 2003, Yan ke xue bao = Eye science.

[23]  Matthew D. Davis,et al.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.

[24]  C. Hedrick,et al.  Increased Production of 12/15 Lipoxygenase Eicosanoids Accelerates Monocyte/Endothelial Interactions in Diabetic db/db Mice* , 2003, Journal of Biological Chemistry.

[25]  Xiaojing Su,et al.  Isolation and characterization of murine retinal endothelial cells. , 2003, Molecular vision.

[26]  Bernd Kirchhof,et al.  Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Rossi,et al.  Adenoviral Delivery of a Leukocyte-Type 12 Lipoxygenase Ribozyme Inhibits Effects of Glucose and Platelet-Derived Growth Factor in Vascular Endothelial and Smooth Muscle Cells , 2001, Circulation research.

[28]  HirokiKurihara,et al.  Overexpression of 15-Lipoxygenase in Vascular Endothelium Accelerates Early Atherosclerosis in LDL Receptor–Deficient Mice , 2000 .

[29]  Y. Ogura,et al.  PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats. , 2000, Investigative ophthalmology & visual science.

[30]  R. Natarajan,et al.  Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[31]  T. Kühme,et al.  The 650-kDa 12(S)-hydroxyeicosatetraenoic acid binding complex: occurrence in human platelets, identification of hsp90 as a constituent, and binding properties of its 50-kDa subunit. , 1999, Archives of biochemistry and biophysics.

[32]  H. Kühn,et al.  The Rabbit 15-Lipoxygenase Preferentially Oxygenates LDL Cholesterol Esters, and This Reaction Does Not Require Vitamin E* , 1998, The Journal of Biological Chemistry.

[33]  J. Cornhill,et al.  Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. , 1996, The Journal of clinical investigation.

[34]  C. Funk.  The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. , 1996, Biochimica et biophysica acta.

[35]  R. Natarajan,et al.  A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease. , 1996, The Journal of clinical endocrinology and metabolism.

[36]  D. Lefer,et al.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. , 1995, The American journal of pathology.

[37]  R. Natarajan,et al.  A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for upregulation by angiotensin II. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[38]  S. Yamamoto,et al.  Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. , 1994, Journal of lipid research.

[39]  W. Glasgow,et al.  Investigation of the oxygenation of phospholipids by the porcine leukocyte and human platelet arachidonate 12-lipoxygenases. , 1993, European journal of biochemistry.

[40]  F. Breviario,et al.  Interleukin-1 increases 15-hydroxyeicosatetraenoic acid formation in cultured human endothelial cells. , 1993, Biochimica et biophysica acta.

[41]  J. Rossi,et al.  Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Schmid-Schönbein,et al.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.

[43]  B. Zetter.  The Endothelial Cells of Large and Small Blood Vessels , 1981, Diabetes.

[44]  P. McGuire,et al.  Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets , 2012, Middle East African journal of ophthalmology.

[45]  平野 佳男.  Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo , 2010 .

[46]  Y. Ogura,et al.  High glucose exacerbates neutrophil adhesion to human retinal endothelial cells. , 2006, Experimental eye research.

[47]  L. Lanting,et al.  Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model , 2002, Diabetologia.

[48]  B Kirchhof,et al.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.

[49]  K. Miyarnoto.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .

[50]  B. Setty,et al.  15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease. , 1986, The Journal of clinical investigation.